135 related articles for article (PubMed ID: 15684507)
21. Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2.
Yang F; Zhou J; Hu X; Yu SK; Liu C; Pan R; Chang Q; Liu X; Liao Y
Drug Deliv Transl Res; 2017 Oct; 7(5):731-737. PubMed ID: 28677033
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects.
Wang Z; Kim U; Jiao Y; Li C; Guo Y; Ma X; Jiang M; Jiang Z; Hou Y; Bai G
J Proteome Res; 2019 May; 18(5):2100-2108. PubMed ID: 30860844
[TBL] [Abstract][Full Text] [Related]
23. One-Pot Synthesis of Ginsenoside Rh2 and Bioactive Unnatural Ginsenoside by Coupling Promiscuous Glycosyltransferase from Bacillus subtilis 168 to Sucrose Synthase.
Dai L; Liu C; Li J; Dong C; Yang J; Dai Z; Zhang X; Sun Y
J Agric Food Chem; 2018 Mar; 66(11):2830-2837. PubMed ID: 29484884
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators.
Cheng Y; Li R; Lin Z; Chen F; Dai J; Zhu Z; Chen L; Zhao Y
Bioorg Med Chem Lett; 2020 Sep; 30(17):127364. PubMed ID: 32738969
[TBL] [Abstract][Full Text] [Related]
25. Complete Bioconversion of Protopanaxadiol-Type Ginsenosides to Compound K by Extracellular Enzymes from the Isolated Strain
Kim SA; Jeong EB; Oh DK
J Agric Food Chem; 2021 Jan; 69(1):315-324. PubMed ID: 33372793
[TBL] [Abstract][Full Text] [Related]
26. Complete Biotransformation of Protopanaxadiol-Type Ginsenosides into 20-
Kim SA; Shin KC; Oh DK
J Agric Food Chem; 2019 Jul; 67(30):8393-8401. PubMed ID: 31291721
[TBL] [Abstract][Full Text] [Related]
27. [Polybasic research on the biopharmaceutical characteristics of 20 (S)-protopanaxadiol].
Jin X; Zhang ZH; Sun E; Tan XB; Xia HJ; Liu QY; Jia XB
Yao Xue Xue Bao; 2013 Mar; 48(3):411-6. PubMed ID: 23724657
[TBL] [Abstract][Full Text] [Related]
28. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
[TBL] [Abstract][Full Text] [Related]
29. Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species.
Zhang Y; Yao L; Tang C; Jiang J; Ye Y; Liu J
Biomed Chromatogr; 2021 Dec; 35(12):e5219. PubMed ID: 34327712
[TBL] [Abstract][Full Text] [Related]
30. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells.
Li G; Wang Z; Sun Y; Liu K; Wang Z
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):588-92. PubMed ID: 16700822
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of the Rhizobium sp. strain GIN611 glycoside oxidoreductase resulting in the deglycosylation of ginsenosides.
Kim EM; Kim J; Seo JH; Park JS; Kim DH; Kim BG
Appl Environ Microbiol; 2012 Jan; 78(1):242-9. PubMed ID: 22020506
[TBL] [Abstract][Full Text] [Related]
33. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
34. Production of rare ginsenosides (compound Mc, compound Y and aglycon protopanaxadiol) by β-glucosidase from Dictyoglomus turgidum that hydrolyzes β-linked, but not α-linked, sugars in ginsenosides.
Lee GW; Kim KR; Oh DK
Biotechnol Lett; 2012 Sep; 34(9):1679-86. PubMed ID: 22648684
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.
Hu C; Lau AJ; Wang R; Chang TKH
Eur J Pharmacol; 2017 Nov; 815():501-511. PubMed ID: 29031898
[TBL] [Abstract][Full Text] [Related]
36. Validated quantification for selective cellular uptake of ginsenosides on MCF-7 human breast cancer cells by liquid chromatography-mass spectrometry.
Ha YW; Ahn KS; Lee JC; Kim SH; Chung BC; Choi MH
Anal Bioanal Chem; 2010 Apr; 396(8):3017-25. PubMed ID: 20169333
[TBL] [Abstract][Full Text] [Related]
37. Ginsenoside 20(S)-Protopanaxadiol Suppresses Viability of Human Glioblastoma Cells via Down-regulation of Cell Adhesion Proteins and Cell-cycle Arrest.
Wanderi C; Kim E; Chang S; Choi C; Choi K
Anticancer Res; 2016 Mar; 36(3):925-32. PubMed ID: 26976980
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a novel recombinant β-glucosidase from Sphingopyxis alaskensis that specifically hydrolyzes the outer glucose at the C-3 position in protopanaxadiol-type ginsenosides.
Shin KC; Oh DK
J Biotechnol; 2014 Feb; 172():30-7. PubMed ID: 24333127
[TBL] [Abstract][Full Text] [Related]
39. Esterification enhanced intestinal absorption of ginsenoside Rh2 in Caco-2 cells without impacts on its protective effects against H₂O₂-induced cell injury in human umbilical vein endothelial cells (HUVECs).
Zhang B; Ye H; Zhu XM; Hu JN; Li HY; Tsao R; Deng ZY; Zheng YN; Li W
J Agric Food Chem; 2014 Mar; 62(9):2096-103. PubMed ID: 24524563
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant-like effects of ginsenosides: A comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair.
Zhang H; Li Z; Zhou Z; Yang H; Zhong Z; Lou C
Pharmacol Biochem Behav; 2016 Jan; 140():17-26. PubMed ID: 26528894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
